Statistics
Publications
11
Citations
3.7K
H-Index
10
Active since
1989
Koji Matsumoto is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, oncology, and pembrolizumab therapy.
Publications per year
1989–2024
11
11
Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text
Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text
Medicine, Oncology, Pharmacology +16
Stereocontrolled total synthesis of (−)-aspidophytine
Shinjiro Sumi, Koji Matsumoto, Hidetoshi Tokuyama et al. · Tetrahedron · 2003 · 72 citations
1–5 of 11